| Oxidized LDL induces in vitro lymphocyte activation in antiphospholipid syndrome. | |
| | |
MedLine Citation:
|
PMID: 20187701 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Oxidized low-density lipoprotein (oxLDL) is a key feature of the atheromatosus plaque and plays a critical role in foam cell formation and perpetuation of inflammatory processes. In antiphospholipid syndrome (APS), oxLDL molecules form complexes with beta2GPI and become target antigens for autoantibodies, which are detectable in the sera of these patients. oxLDL takes part in the pathogenesis of APS and in the concomitant accelerated atherosclerosis, yet the exact associated immune mechanisms are not clear in details. The aim of this study was to assess the activation and proliferation response of peripheral blood mononuclear cells (PBMCs) derived from patients with APS in the presence of oxLDL. Thirteen patients with APS and nine healthy individuals were enrolled in the study. Separated PBMCs of these patients were cultured in the presence of immunogenic epitope of oxLDL. Lymphocyte proliferation and cytokine secretion (TNF-alpha, IL-2, IFN-gamma, IL-4, and IL-10) were assessed by ELISA. We found significant PBMC proliferation in APS compared to healthy controls (PI/proliferation index/APS: 1.76 vs. PI control: 0.56; p = 0.032). A significant IL-2 and IFN-gamma secretion were detected upon oxLDL stimulus in patients with APS compared to controls (IL-2 cytokine secretion index (CSI) APS: 278.5, IL-2 CSI controls: 65.1; p = 0.025; IFN-gamma CSI APS: 163.2, IFN-gamma CSI controls: 77.4; p = 0.025). Based on our findings, we assume that oxLDL via Th1-type cytokine production and lymphocyte proliferation may contribute to the perpetuation of immune processes in APS. |
| | |
Authors:
|
Renata Laczik; Peter Szodoray; Katalin Veres; Gabriella Lakos; Sandor Sipka; Gyula Szegedi; Pal Soltész |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Autoimmunity Volume: 43 ISSN: 1607-842X ISO Abbreviation: Autoimmunity Publication Date: 2010 Jun |
Date Detail:
|
Created Date: 2010-05-14 Completed Date: 2010-08-24 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8900070 Medline TA: Autoimmunity Country: England |
Other Details:
|
Languages: eng Pagination: 334-9 Citation Subset: IM |
Affiliation:
|
Intensive Care Unit, 3rd Department of Medicine, Institute of Internal Medicine, University of Debrecen Medical and Health Science Center, Móricz Zs Street 22, 4004 Debrecen, Hungary. renata.laczik@gmail.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Antiphospholipid Syndrome / blood, complications, immunology* Atherosclerosis / complications, etiology, immunology Cytokines / secretion Female Humans Interleukin-2 / biosynthesis Leukocytes, Mononuclear / immunology Lipoproteins, LDL / immunology* Lymphocyte Activation / immunology* Male Middle Aged |
| Chemical | |
Reg. No./Substance:
|
0/Cytokines; 0/Interleukin-2; 0/Lipoproteins, LDL; 0/oxidized low density lipoprotein |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Comparison of percutaneous balloon compression and glycerol rhizotomy for the treatment of trigemina...
Next Document: The type I interferon system in idiopathic inflammatory myopathies.